Products & Services · Additions
Net product sales — Additions
Moderna Net product sales — Additions decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Over 4 years (FY 2021 to FY 2025), Net product sales — Additions shows a downward trend with a -69.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryProfitability
SignalLower is better
VolatilityVolatile
First reportedQ1 2020
Last reportedQ1 2026May 1, 2026
How to read this metric
Increasing additions may signal higher anticipated pricing pressure, increased competition, or a change in product return expectations.
Detailed definition
This metric tracks the new provisions or increases to existing liabilities for variable consideration, such as estimated...
Peer comparison
Similar to 'provision for sales returns and allowances' found in the income statement footnotes of most pharmaceutical companies.
Metric ID:
mrna_segment_net_product_sales_additionsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.68B | $3.47B | $2.04B | $1.76B | $79.00M | $633.00M | $43.00M | $45.00M | $82.00M | $80.00M | $308.00M | $14.00M | $182.00M | $28.00M | $1.00M | $0.00 | $84.00M | $0.00 | $24.00M | $0.00 |
| QoQ Change | — | +106.8% | -41.2% | -14.1% | -95.5% | +701.3% | -93.2% | +4.7% | +82.2% | -2.4% | +285.0% | -95.5% | >999% | -84.6% | -96.4% | -100.0% | — | -100.0% | — | -100.0% |
| YoY Change | — | — | — | — | -95.3% | -81.8% | -97.9% | -97.4% | +3.8% | -87.4% | +616.3% | -68.9% | +122.0% | -65.0% | -99.7% | -100.0% | -53.8% | -100.0% | >999% | — |
Range$0.00 – $3.47B
CAGR-100.0%
Avg YoY Growth+139.7%
Median YoY Growth-81.8%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Moderna's net product sales — additions?
- Moderna (MRNA) reported net product sales — additions of $0.00 in Q1 2026.
- What is the long-term trend for Moderna's net product sales — additions?
- Over 4 years (2021 to 2025), Moderna's net product sales — additions has grown at a -69.0% compound annual growth rate (CAGR), from $11.66B to $108.00M.
- What does net product sales — additions mean?
- The amount added to the reserve for future sales deductions during the current period.